Spectrum Wealth Counsel, LLC Pacira Bio Sciences, Inc. Transaction History
Spectrum Wealth Counsel, LLC
- $847 Billion
- Q3 2024
A detailed history of Spectrum Wealth Counsel, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Spectrum Wealth Counsel, LLC holds 600 shares of PCRX stock, worth $11,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600
Previous 600
-0.0%
Holding current value
$11,897
Previous $17.2 Million
47.4%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
264Shares Held
50.6MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$105 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$98.4 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$39.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$39.2 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $909M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...